Literature DB >> 10068105

Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study.

M Gschwantler1, J Vavrik, A Gebauer, S Kriwanek, C Schrutka-Kölbl, J Fleischer, B Madani, E Brownstone, D Tscholakoff, W Weiss.   

Abstract

BACKGROUND/AIMS: The pathogenesis of thrombocytopenia associated with advanced liver disease is still controversial. To study the impact of portal decompression on this hematologic complication, we conducted a prospective, controlled study to compare the course of platelet counts in patients after implantation of a transjugular intrahepatic portosystemic shunt (TIPS) with matched controls without shunts.
METHODS: Fifty-five TIPS patients and 110 controls matched for age, sex, Child-Pugh class, etiology of liver disease and baseline platelet count were included, and followed for 1 year. Follow-up visits were scheduled after 1 month, after 3 months, and at 3-month intervals thereafter.
RESULTS: Nonparametric Mann-Whitney U-tests revealed significantly higher platelet counts for TIPS patients as compared to controls from the 1st through the 12th month (p<0.01). During the study period, the median platelet count of TIPS patients increased by 19.7%, from 104.0/nl (IR: 68.0) to 124.5/nl (IR: 41.0). In contrast, during the same period the median platelet count of controls decreased by 17.1%, from 102.5/nl (IR: 66.0) to 85.0/nl (IR: 67.5). In the group of cases with baseline platelet counts < or =100/nl, platelet counts had increased by at least 25% at month 12 in 65% of TIPS patients, but in only 5% of controls (p<0.001). However, normalization of platelet counts, i.e. > or =150/nl, was not achieved in any case. Neither the portosystemic pressure gradient after TIPS implantation, nor the percentage of portosystemic pressure gradient reduction during the procedure was predictive of platelet response.
CONCLUSIONS: TIPS implantation increases platelet counts significantly. However, portal hypertension is clearly not the only mechanism contributing to thrombocytopenia in advanced liver disease.

Entities:  

Mesh:

Year:  1999        PMID: 10068105     DOI: 10.1016/s0168-8278(99)80071-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

2.  The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.

Authors:  Omar I Massoud; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

3.  Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.

Authors:  Theresa Bucsics; Katharina Lampichler; Constantin Vierziger; Maria Schoder; Florian Wolf; David Bauer; Benedikt Simbrunner; Lukas Hartl; Mathias Jachs; Bernhard Scheiner; Michael Trauner; Thomas Gruenberger; Franz Karnel; Mattias Mandorfer; Thomas Reiberger
Journal:  Dig Dis Sci       Date:  2022-03-17       Impact factor: 3.199

Review 4.  Abnormal hematological indices in cirrhosis.

Authors:  A A Qamar; N D Grace
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

5.  Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.

Authors:  Elise J Barney; Ester C Little; Richard D Gerkin; Alberto X Ramos; Jeffrey Kahn; Mark Wong; Geetha Kolli; Richard Manch
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

6.  Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology.

Authors:  Masatoshi Ishigami; Yoji Ishizu; Yasuharu Onishi; Hideya Kamei; Tetsuya Kiuchi; Akihiro Itoh; Yoshiki Hirooka; Yoshiaki Katano; Hidemi Goto
Journal:  Springerplus       Date:  2013-08-07

7.  Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.

Authors:  Yingying Li; Zuojin Liu; Chang'an Liu
Journal:  BMC Gastroenterol       Date:  2021-02-11       Impact factor: 3.067

8.  Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia.

Authors:  Na Li; Nancy M Heddle; Ishac Nazy; John G Kelton; Donald M Arnold
Journal:  Blood Adv       Date:  2021-10-26

9.  Utility of Doppler ultrasonography for predicting improvement of platelet count after transjugular intrahepatic portosystemic shunt.

Authors:  Kianoush Ansari-Gilani; Babak Seddigh Tonekaboni; Dean A Nakamoto; Jamak Modaresi Esfeh
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.